Found: 34
Select item for more details and to access through your institution.
Estimating Residence Times and Their Associated Errors in Patient Absorbed-Dose Calculation.
- Published in:
- Journal of Nuclear Medicine Technology, 1997, v. 25, n. 4, p. 264
- By:
- Publication type:
- Article
A Shielded, Automated Injector for Energetic Beta-Emitting Radionuclides.
- Published in:
- Journal of Nuclear Medicine Technology, 1995, v. 23, n. 1, p. 29
- By:
- Publication type:
- Article
Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy.
- Published in:
- 1990
- By:
- Publication type:
- journal article
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 10, p. 925, doi. 10.1038/nbt.1564
- By:
- Publication type:
- Article
Low Dose Focused Ultrasound Induces Enhanced Tumor Accumulation of Natural Killer Cells.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0142767
- By:
- Publication type:
- Article
Intratumoral immunocytokine treatment results in enhanced antitumor effects.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1891, doi. 10.1007/s00262-008-0519-0
- By:
- Publication type:
- Article
Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange.
- Published in:
- Protein Engineering, 2001, v. 14, n. 12, p. 1025, doi. 10.1093/protein/14.12.1025
- By:
- Publication type:
- Article
Human Monoclonal Antibodies against Group A Red Blood Cells.
- Published in:
- Vox Sanguinis, 1985, v. 48, n. 5, p. 305, doi. 10.1111/j.1423-0410.1985.tb00186.x
- By:
- Publication type:
- Article
The two types of correction of absorbed dose estimates for internal emitters.
- Published in:
- Cancer (0008543X), 2002, v. 94, n. S4, p. 1231, doi. 10.1002/cncr.10290
- By:
- Publication type:
- Article
Tumor Uptake of <sup>64</sup>Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 1, p. 38, doi. 10.2967/jnumed.117.193888
- By:
- Publication type:
- Article
Functional Imaging of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Using <sup>64</sup>Cu-DOTA-Trastuzumab PET.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 1, p. 23, doi. 10.2967/jnumed.113.122630
- By:
- Publication type:
- Article
Quantitative, Simultaneous PET/MRI for Intratumoral Imaging with an MRI-Compatible PET Scanner.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 7, p. 1102, doi. 10.2967/jnumed.111.099861
- By:
- Publication type:
- Article
Monodispersed DOTA-PEG-Conjugated Anti-TAG-72 Diabody Has Low Kidney Uptake and High Tumor-to-Blood Ratios Resulting in Improved <sup>64</sup>Cu PET.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 7, p. 1139, doi. 10.2967/jnumed.109.074153
- By:
- Publication type:
- Article
Recombinant Anti-CD20 Antibody Fragments for Small-Animal PET Imaging of B-Cell Lymphomas.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 9, p. 1500, doi. 10.2967/jnumed.108.060426
- By:
- Publication type:
- Article
Truncation of blood curves to enhance imaging and therapy with monoclonal antibodies.
- Published in:
- Medical Physics, 2000, v. 27, n. 5, p. 988, doi. 10.1118/1.598963
- By:
- Publication type:
- Article
A CT assisted method for absolute quantitation of internal radioactivity.
- Published in:
- Medical Physics, 1996, v. 23, n. 11, p. 1919, doi. 10.1118/1.597755
- By:
- Publication type:
- Article
Figures of merit (FOMs) for imaging and therapy using monoclonal antibodies.
- Published in:
- Medical Physics, 1995, v. 22, n. 12, p. 2025, doi. 10.1118/1.597646
- By:
- Publication type:
- Article
On the correction for radioactive decay in pharmacokinetic modeling.
- Published in:
- Medical Physics, 1995, v. 22, n. 10, p. 1619, doi. 10.1118/1.597421
- By:
- Publication type:
- Article
53. Preliminary Results of a Pilot Phase I Clinical Trial of Adoptive Immunotherapy for B Cell Lymphoma Using CD8+ T Cells Genetically Modified To Express a Chimeric T Cell Receptor Recognizing CD20.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S22, doi. 10.1016/j.ymthe.2006.08.068
- By:
- Publication type:
- Article
Cellular Immunotherapy for Follicular Lymphoma Using Genetically Modified CD20-Specific CD8<sup>+</sup> Cytotoxic T Lymphocytes
- Published in:
- Molecular Therapy, 2004, v. 9, n. 4, p. 577, doi. 10.1016/j.ymthe.2003.12.011
- By:
- Publication type:
- Article
A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2013, v. 26, n. 3, p. 187, doi. 10.1093/protein/gzs096
- By:
- Publication type:
- Article
ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies).
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2010, v. 23, n. 4, p. 243, doi. 10.1093/protein/gzp081
- By:
- Publication type:
- Article
Humanization of the anti-CEA T84.66 antibody based on crystal structure data.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2004, v. 17, n. 5, p. 481, doi. 10.1093/protein/gzh056
- By:
- Publication type:
- Article
Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2004, v. 17, n. 4, p. 315, doi. 10.1093/protein/gzh040
- By:
- Publication type:
- Article
Covalent disulfide‐linked anti‐CEA diabody allows site‐specific conjugation and radiolabeling for tumor targeting applications.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2004, v. 17, n. 1, p. 21, doi. 10.1093/protein/gzh009
- By:
- Publication type:
- Article
Imaging Glioma Extent with <sup>131</sup>I-TM-601.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 4, p. 580
- By:
- Publication type:
- Article
<sup>124</sup>I-Labeled Engineered Anti-CEA Minibodies and Diabodies Allow High-Contrast, Antigen-Specific Small-Animal PET Imaging of Xenografts in Athymic Mice.
- Published in:
- Journal of Nuclear Medicine, 2003, v. 44, n. 12, p. 1962
- By:
- Publication type:
- Article
A Radionuclide Therapy Treatment Planning and Dose Estimation System.
- Published in:
- Journal of Nuclear Medicine, 1999, v. 40, n. 7, p. 1151
- By:
- Publication type:
- Article
Similarities and Differences in <sup>111</sup>ln- and <sup>90</sup>Y-Labeled 1B4M-DTPA AntiTac Monoclonal Antibody Distribution.
- Published in:
- Journal of Nuclear Medicine, 1999, v. 40, n. 2, p. 268
- By:
- Publication type:
- Article
Dose Escalation Trial of Indium-111-Labeled Anti-Carcinoembryonic Antigen Chimeric Monoclonal Antibody (Chimeric T84.66) in Presurgical Colorectal Cancer Patients.
- Published in:
- Journal of Nuclear Medicine, 1998, v. 39, n. 12, p. 2097
- By:
- Publication type:
- Article
Clinical Evaluation of Indium-111-Labeled Chimeric Anti-CEA Monoclonal Antibody.
- Published in:
- Journal of Nuclear Medicine, 1997, v. 38, n. 12, p. 1951
- By:
- Publication type:
- Article
Pharmacokinetic Modeling and Absorbed Dose Estimation for Chimerie Anti-CEA Antibody in Humans.
- Published in:
- Journal of Nuclear Medicine, 1997, v. 38, n. 12, p. 1959
- By:
- Publication type:
- Article
Modeling of Tumor Uptake to Determine the Time-Dose-Fractionation Effect in Radioimmunotherapy.
- Published in:
- Journal of Nuclear Medicine, 1994, v. 35, n. 9, p. 1561
- By:
- Publication type:
- Article
Comparative Biodistributions of Yttrium- and Indium-Labeled Monoclonal Antibody B72.3 in Athymic Mice Bearing Human Colon Carcinoma Xenografts.
- Published in:
- Journal of Nuclear Medicine, 1989, v. 30, n. 5, p. 672
- By:
- Publication type:
- Article